Common Stock, Shares Authorized of AXIM BIOTECHNOLOGIES, INC. from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Axim Biotechnologies, Inc. quarterly Common Stock, Shares Authorized history and change rate from Q4 2010 to Q2 2024.
  • Axim Biotechnologies, Inc. Common Stock, Shares Authorized for the quarter ending 30 Jun 2024 was 1B shares, a 233% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 1B +700M +233% 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 1B +700M +233% 31 Mar 2024 10-Q/A 22 May 2024
Q4 2023 1B 0 0% 31 Dec 2023 10-Q 19 Aug 2024
Q3 2023 1B +700M +233% 30 Sep 2023 10-Q 20 Nov 2023
Q2 2023 300M 0 0% 30 Jun 2023 10-Q 21 Aug 2023
Q1 2023 300M 0 0% 31 Mar 2023 10-Q 22 May 2023
Q4 2022 1B +700M +233% 31 Dec 2022 10-K 16 Apr 2024
Q3 2022 300M 0 0% 30 Sep 2022 10-Q/A 15 Nov 2022
Q2 2022 300M 0 0% 30 Jun 2022 10-Q 16 Aug 2022
Q1 2022 300M 0 0% 31 Mar 2022 10-Q 23 May 2022
Q4 2021 300M 0 0% 31 Dec 2021 10-K 17 Apr 2023
Q3 2021 300M 0 0% 30 Sep 2021 10-Q 22 Nov 2021
Q2 2021 300M 30 Jun 2021 10-Q 23 Aug 2021
Q1 2021 300M 0 0% 31 Mar 2021 10-Q/A 02 Jun 2021
Q4 2020 300M 0 0% 31 Dec 2020 10-K/A 19 Apr 2022
Q3 2020 300M 0 0% 30 Sep 2020 10-Q/A 27 Nov 2020
Q1 2020 300M 0 0% 31 Mar 2020 10-Q/A 02 Jul 2020
Q4 2019 300M 0 0% 31 Dec 2019 10-Q/A 27 Nov 2020
Q3 2019 300M 0 0% 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 300M 0 0% 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 300M 0 0% 31 Mar 2019 10-Q 15 May 2019
Q4 2018 300M 0 0% 31 Dec 2018 10-K 08 Apr 2019
Q3 2018 300M 0 0% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 300M 0 0% 30 Jun 2018 10-Q/A 17 Aug 2018
Q1 2018 300M 0 0% 31 Mar 2018 10-Q/A 18 May 2018
Q4 2017 300M 0 0% 31 Dec 2017 10-Q 14 Nov 2018
Q3 2017 300M 0 0% 30 Sep 2017 10-Q 20 Nov 2017
Q2 2017 300M 0 0% 30 Jun 2017 10-Q/A 14 Sep 2017
Q1 2017 300M 0 0% 31 Mar 2017 10-Q/A 14 Sep 2017
Q4 2016 300M 0 0% 31 Dec 2016 10-Q/A 14 Sep 2017
Q3 2016 300M 0 0% 30 Sep 2016 10-Q/A 30 Nov 2016
Q2 2016 300M 0 0% 30 Jun 2016 10-Q/A 25 Aug 2016
Q1 2016 300M 0 0% 31 Mar 2016 10-Q/A 26 May 2016
Q4 2015 300M 0 0% 31 Dec 2015 10-K/A 14 Sep 2017
Q3 2015 300M 0 0% 30 Sep 2015 10-Q 23 Nov 2015
Q2 2015 300M +105M +53.8% 30 Jun 2015 10-Q/A 27 Aug 2015
Q1 2015 300M +105M +53.8% 31 Mar 2015 10-Q 13 May 2015
Q4 2014 300M +105M +53.8% 31 Dec 2014 10-K/A 18 Apr 2016
Q3 2014 300M +105M +53.8% 30 Sep 2014 10-Q 14 Nov 2014
Q2 2014 195M 0 0% 30 Jun 2014 10-Q/A 26 Aug 2014
Q1 2014 195M 0 0% 31 Mar 2014 10-Q/A 18 Jun 2014
Q4 2013 195M 0 0% 31 Dec 2013 10-K 14 Apr 2015
Q3 2013 195M 0 0% 30 Sep 2013 10-Q 18 Nov 2013
Q2 2013 195M 0 0% 30 Jun 2013 10-Q 14 Aug 2013
Q1 2013 195M 0 0% 31 Mar 2013 10-Q 15 May 2013
Q4 2012 195M 0 0% 31 Dec 2012 10-K 04 Mar 2014
Q3 2012 195M 0 0% 30 Sep 2012 10-Q 19 Nov 2012
Q2 2012 195M 30 Jun 2012 10-Q 14 Aug 2012
Q1 2012 195M 31 Mar 2012 10-Q 17 May 2012
Q4 2011 195M 0 0% 31 Dec 2011 10-K 15 Apr 2013
Q3 2011 195M 30 Sep 2011 10-Q/A 21 Nov 2011
Q4 2010 195M 31 Dec 2010 10-K/A 01 May 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.